Data protection Impressum

Medtech

With over 30 years of presence in Le Locle, Jabil has established itself as a key player in Neuchâtel’s advanced manufacturing landscape.

Jabil, driving medical innovation from the heart of Neuchâtel’s industrial ecosystem

2 April 2025

Bern-based medtech company machineMD has announced a strategic partnership with Topcon Healthcare. The collaboration aims to integrate machineMD’s neurodiagnostic technology with Topcon’s digital health platform, paving the way for earlier and more precise detection of neurological diseases within a connected care ecosystem.

Neurodiagnostics specialist machineMD secures strategic investment from Topcon Healthcare

24 March 2025

The Foundation for Technological Innovation (FIT) has awarded funding to promising Western Switzerland start-ups PeriVision, Bioscibex, and Carewell, to accelerate their development in healthtech and biotechnology.

Western Switzerland innovators PeriVision, Bioscibex and Carewell receive support from FIT

17 March 2025

A research team at .NeuroRestore (EPFL/CHUV/UNIL) has developed an innovative rehabilitation approach that combines robotic-assisted therapy with spinal cord stimulation, offering new hope for individuals with spinal cord injuries.

.NeuroRestore’s breakthrough in robotics and spinal stimulation restores mobility after paralysis

17 March 2025

Lausanne-based Limula has introduced LimONE, a fully automated cell therapy manufacturing platform designed to streamline production, reduce costs, and improve accessibility for patients. The company expects to deliver the first units by 2028.

Limula unveils LimONE, a breakthrough in automated cell therapy manufacturing

10 March 2025

Innovaud has awarded the Scale-Up Vaud 2025 label to 42 high-growth companies, including nine new entrants, reinforcing the region’s dynamic innovation ecosystem.

Business environment

42 Vaud-based companies awarded Scale-Up Vaud 2025 label

3 March 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (February 2025)

25 February 2025

Biotech company CELLnTEC is playing a key role in the NEOLIVER project, a European-Swiss initiative developing the world’s first autologous bioprinted liver for clinical use. The project, co-funded by the EU and the Swiss government, aims to address the global organ donor shortage through innovative bioprinting technologies.

Bern-based CELLnTEC joins NEOLIVER project to develop bioprinted liver constructs

10 February 2025

The Foundation for Innovation and Technology has awarded Tech Grants to five promising projects from CHUV, EPFL, and HEIG-VD. The grants will support innovations in medical technology, robotics, and sustainable agriculture.

FIT awards Tech Grants to five cutting-edge projects from CHUV, EPFL and HEIG-VD

5 February 2025

Swiss start-ups raised CHF 2.4 billion in venture capital in 2024, marking an 8.5% decline from the previous year. The number of financing rounds also fell for the first time, reflecting a challenging investment climate. Despite these setbacks, biotech and cleantech sectors saw strong growth, and investor sentiment remains optimistic for 2025.

Swiss start-ups secure CHF 2.4 billion in 2024 amid shifting investment trends

4 February 2025

1 2 3 4 5 … 15